A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

NCT02725515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: XmAb5871
BIOLOGICAL: Placebo to match XmAb5871

Sponsor

Xencor, Inc.

Collaborators

[object Object]
[object Object]